MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $27,160,000 | +351.9% | 450,401 | +237.3% | 0.04% | +288.9% |
| Q1 2016 | $6,010,000 | -43.8% | 133,519 | -40.1% | 0.01% | -30.8% |
| Q4 2015 | $10,702,000 | -46.8% | 222,963 | -53.5% | 0.01% | -48.0% |
| Q3 2015 | $20,126,000 | +27.9% | 479,198 | +247.1% | 0.02% | +38.9% |
| Q2 2015 | $15,737,000 | -4.9% | 138,038 | +7.6% | 0.02% | 0.0% |
| Q1 2015 | $16,553,000 | +24.5% | 128,313 | -4.5% | 0.02% | +38.5% |
| Q4 2014 | $13,299,000 | -42.8% | 134,320 | -43.4% | 0.01% | -40.9% |
| Q3 2014 | $23,250,000 | +104.7% | 237,240 | +60.8% | 0.02% | +83.3% |
| Q2 2014 | $11,360,000 | -65.1% | 147,547 | -71.0% | 0.01% | -67.6% |
| Q1 2014 | $32,563,000 | +240.7% | 508,817 | +235.4% | 0.04% | +270.0% |
| Q4 2013 | $9,558,000 | -10.5% | 151,718 | -16.2% | 0.01% | -23.1% |
| Q3 2013 | $10,678,000 | +183.5% | 180,984 | +136.4% | 0.01% | +225.0% |
| Q2 2013 | $3,767,000 | – | 76,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |